Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Standard view
Full view
of .
Look up keyword
Like this
0 of .
Results for:
No results containing your search query
P. 1
Celliant (diabetes)

Celliant (diabetes)

Ratings: (0)|Views: 25|Likes:
Published by Amy Tenderich

More info:

Published by: Amy Tenderich on Apr 30, 2010
Copyright:Attribution Non-commercial


Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less





Celliant Overview
DiabetesMine Design ChallengeHologenix, LLCalex.vonhungen@celliant.com April 27, 2010
People with diabetes can develop many different types of foot problems.Most often these problems occur when there is nerve damage, also calledneuropathy, which results in loss of feeling in the feet or lower legs. Poor blood flowmay also cause additional problems including peripheral vascular disease. Evenseemingly ordinary problems can worsen and lead to more serious complications.About sixty to seventy percent of people with diabetes have some form of neuropathy (NDIC, 2009). Symptoms of this can include numbness or tingling,indigestion, vomiting, diarrhea, constipation, dizziness, problems with urination,erectile dysfunction and weakness, along with the emotional difficulties that develop from these symptoms. The risk of diabetics developing peripheral vasculardisease is two to four times as likely as an otherwise healthy individual (Wikipedia,2010). The effects of peripheral vascular disease can be devastating. In fact,seventy percent of nontramautic amputations are performed on diabetics withperipheral vascular disease. Currently diabetics with these conditions are treatedwith a multitude of medications or even surgery both of which can cause even morecomplications.Hologenix, LLC, the makers of Celliant 
, have developed a non‐invasive,completely safe way of treating diabetics suffering from vascular and neuropathicconditions. Wearing garments made with Celliant yarn or sleeping in a bed madewith Celliant can dramatically improve circulation and increase oxygen levels in thebody reducing pain and discomfort.Celliant is a technology that improves transcutaneous oxygen (TCPO
) levelsby embedding polyester yarn with photosensitive minerals. The mineralsembedded in each strand of yarn use the electromagnetic energy emitted by thebody in the form of infrared light and heat to vasodilate blood vessels. This allowsmore oxygenated blood to reach areas of the body that have poor circulation.Celliant is a bi‐component fiber. This means that the core of the fiber isseparate from that sheath and the minerals can be added to only the core of thefiber. Most of the additives are under one micron is size. For reference, a humanhair is typically anywhere from 17 to 180 microns. Because these minerals are sosmall and only found in the core of the fiber they can be treated like almost anyother yarn when they are made into fabrics and garments. This means diabetics cantreat their conditions without the risk of side effects and with no more effort thanputting on their socks in the morning, or laying down in bed to go to sleep at night.
 [Fig. 1. 2,000x magnification of a cross section of Celliant Fiber]How can a non‐invasive product be so effective at treating these conditionswhen most medications do not even work as well? The key is near‐infrared therapy.The exact mechanism by which this therapy works is still being explored byresearchers and scientists worldwide, but significant peer‐reviewed clinical testinghas been published supporting the ability of low level laser therapy (Whelan, 2001)to affect biochemical processes in the body. Most significant of these is the ability toinfluence up and down‐regulation of nitric oxide levels and adenosine triphosphate(ATP).ATP is the primary means in which the body receives energy. Put simply,when the body has access to ATP it can produce energy much more efficientlydecreasing fatigue and increasing muscle recovery times. Energy regulation is agreat benefit but it is not the key benefit for diabetics. The key for them is nitricoxide. Nitric oxide has a half‐life of only a few seconds but it is an extremelyimportant signaling molecule in the body. The signals it gives control theendolithium (smooth muscle walls of the blood vessels) causing blood vessels toeither contract or relax. Contracted blood vessels are the key reason for the painand tingling associated with peripheral vascular disease.What we know from clinical tests among patients with diabetic neuropathy,peripheral vascular disease and other conditions, is that Celliant was shown tocause statistically significant reductions in foot pain. This is a big deal! The studywas performed by Dr. Ian Gordon at the University of California, Irvine and waspublished in the Journal of Alternative and Contemporary Medicine in 2008. Dr.Gordon was able to show in a double‐blind study that patients showed a 2.7xreduction in pain on the McGill Short Form Pain Survey, an industry accepted scalefor measuring pain relief that is used in FDA trials for pain medication.Dr. Lawrence Lavery, DPM, MPH, a diabetic specialist who has published over100 peer‐reviewed papers, performed one of three independent clinical studies

You're Reading a Free Preview

/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->